Efficacy and safety of add on therapies in patients with hypercholesterolemia undergoing statin therapy

Pharmacology, Toxicology and Pharmaceutical Science

• Add on Therapy 100%
• Alirocumab 20%
• Bempedoic Acid 20%
• Evolocumab 20%
• Ezetimibe 20%
• Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor 60%
• Hypercholesterolemia 100%
• Inclisiran 20%
• Low Density Lipoprotein Cholesterol 100%
• Monoclonal Antibody 40%
• Proprotein Convertase 9 60%
• Small Interfering RNA 20%
• Statin (Protein) 100%
• Tolerability 40%